Efficacy and safety of repository corticotropin injection for refractory cutaneous dermatomyositis: a prospective, open-label study.
Anthony P FernandezJosh GallopSamantha PollyUrmi KhannaPublished in: Rheumatology (Oxford, England) (2023)
This clinical trial was registered with ClinicalTrials.gov (ClinicalTrials.gov Identifier: NCT01906372).